Patients with LGMD-R21 exhibit progressive muscle weakness, accompanied by reduced NOTCH1 signaling and a decrease in the number of satellite cells marked by PAX7 expression (Servian-Morilla et al., 2020; Servian-Morilla et al., 2016). The gene discussed is PAX7; the disease is limb-girdle muscular dystrophy.